GLP-1 drugs are reshaping our bodies, but also our society. They may even help to treat major diseases once thought incurable ...

President Donald Trump’s comments about autism this week sparked widespread concern and criticism from many in the community.

GLP-1 receptor agonists and SGLT2 inhibitors are linked to greater reduction in risk for Alzheimer’s disease than DPP-4 ...

Animal studies say rapamycin can slow aging – but does it work in humans? A new review finds the evidence for the off-label, ...

Chinese biotech firm is among dozens of mainland drug makers seeking to compete in the global market for diabetes and ...

The agency expanded use of an old drug as a treatment for some people with autism. The endorsement sent some customers ...

A controversial anti-parasitic drug said without evidence to be a treatment for COVID-19 could be available over the counter.

Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the ...

According to Martin Makary, head of the US Food and Drug Administration (FDA), the drug leucovorin will help “hundreds of ...

Recently, a different weight loss drug, ecnoglutide, with an active ingredient of the peptide ecnoglutide, has been utilized ...

The play asks whether two subjects in a clinical trial are madly in love or it’s just the drugs they’re taking ...

The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid ...